Další formáty:
BibTeX
LaTeX
RIS
@proceedings{1228919,
author = {Bešše, Lenka and Drandi, Daniela and Sedlaříková, Lenka and Oliva, Stefania and Gambella, Manuela and Omedè, Paola and Adam, Zdeněk and Pour, Luděk and Ševčíková, Sabina and Boccadoro, Mario and Palumbo, Antonio and Hájek, Roman},
booktitle = {56th Annual Meeting of the American Society of Hematology},
keywords = {Cell-Free DNA; Multiple Myeloma},
language = {eng},
title = {Cell-Free DNA for Minimal Residual Disease Monitoring in Multiple Myeloma Patients},
year = {2014}
}
TY - CONF
ID - 1228919
AU - Bešše, Lenka - Drandi, Daniela - Sedlaříková, Lenka - Oliva, Stefania - Gambella, Manuela - Omedè, Paola - Adam, Zdeněk - Pour, Luděk - Ševčíková, Sabina - Boccadoro, Mario - Palumbo, Antonio - Hájek, Roman
PY - 2014
TI - Cell-Free DNA for Minimal Residual Disease Monitoring in Multiple Myeloma Patients
KW - Cell-Free DNA
KW - Multiple Myeloma
N2 - Circulating nucleic acids, such as cell-free DNA (cf-DNA), are becoming a promising minimally-invasive diagnostic tool for cancer detection. Recent studies demonstrated that tumor-derived cf-DNA can be used to monitor tumor burden and response to treatment in patients (pts) with solid tumors as well as hematological malignancies (Dawson et al, 2013, Armand et al, 2013). In this study we investigated the clinical utility of cf-DNA in the monitoring of minimal residual disease (MRD) of pts with multiple myeloma (MM) carrying the tumor specific immunoglobulin (IGH) rearrangement.
ER -
BEŠŠE, Lenka, Daniela DRANDI, Lenka SEDLAŘÍKOVÁ, Stefania OLIVA, Manuela GAMBELLA, Paola OMEDÈ, Zdeněk ADAM, Luděk POUR, Sabina ŠEVČÍKOVÁ, Mario BOCCADORO, Antonio PALUMBO a Roman HÁJEK. Cell-Free DNA for Minimal Residual Disease Monitoring in Multiple Myeloma Patients. In \textit{56th Annual Meeting of the American Society of Hematology}. 2014.
|
